Table 1.
(i) Activates quiescent fibroblasts into myofibroblasts |
(ii) Increases fibronectin production by fibroblast and MC |
(iii) Induces the expression of connective tissue growth factor (CTGF) by MC |
(iv) Stimulates the synthesis of PAI, the natural inhibitor of tPA, contributing to the generation of an antifibrinolytic environment |
(v) Increases matrix synthesis and inhibits matrix degradation by decreasing the ratio MMPs/TIMPs |
(vi) Induces MMT of MC |